Differential modulation of Ahr and Arid5a: A promising therapeutic strategy for autoimmune encephalomyelitis
Multiple sclerosis (MS) is an autoimmune disease that involves demyelination of axons in the central nervous system (CNS) and affects patients worldwide. It has been demonstrated that ligand-activated aryl hydrocarbon receptor (Ahr) ameliorates experimental autoimmune encephalomyelitis (EAE), a muri...
Main Authors: | Abdullah Alzahrani, Hamza Hanieh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016420302425 |
Similar Items
-
Therapeutic effect of nucleoside analogs on experimental autoimmune encephalomyelitis in dark agouti rats
by: Stojkov Danijela, et al.
Published: (2006-01-01) -
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
by: Leonie Stolz, et al.
Published: (2017-07-01) -
Epigenetic Regulations of AhR in the Aspect of Immunomodulation
by: Anna Wajda, et al.
Published: (2020-09-01) -
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
by: Kaili Lu, et al.
Published: (2020-02-01) -
Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells
by: Haikuo Xue, et al.
Published: (2016-05-01)